Abstract:Highly specific and efficient drugs have been developed during the last two decades to treat non-communicable chronic inflammatory skin diseases (ncISD). Due to their specificity, these drugs are asking for precise diagnostic measures to attribute the most efficient treatment to each patient. Diagnosis, however, is complicated by the complex pathogenesis of ncISD and their clinical and histological overlap. Especially, precise diagnosis of psoriasis and eczema is difficult in special cases and molecular diagnostic tools need to be developed to support gold standard diagnosis of patients. In this line, we have developed a real-time based molecular classifier to distinguish psoriasis from eczema in RNA-later fixed skin samples. However, this type of skin sample is not regularly used in routine diagnostics. Therefore, we evaluated if the combination of NOS2 and CCL27 expression in lesional skin can be transferred to formalin-fixed paraffin embedded (FFPE) tissue. We present a FFPE-based molecular classifier (MC) that determines the probability for psoriasis with a specificity and sensitivity of 100% and 92%, respectively, and an area under the curve (AUC) of 0.97 delivering comparable results to the RNA-later based MC. The probability for psoriasis as well as the PCR result of NOS2 expression correlated positive with disease hallmarks of psoriasis and negative with eczema hallmarks. This tool now offers broad usage in pathology laboratories and can support diagnostic decision making on a molecular level.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis work was supported by the Medical Valley Award.### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the ethical committee of the Klinikum rechts der Isar, Technical University Munich (project number 2773/10 and 515/17)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGenerated data and codes can be provided upon request

Documentation of psoriasis in routine care – expert consensus on a German data set

Expert Consensus on the Treat-to-target Strategy for Psoriasis with Biological Agents in China

Gene Expression Based Molecular Test Proves Clinical Validity As Diagnostic Aid for the Differential Diagnosis of Psoriasis and Eczema in Formalin Fixed and Paraffin Embedded Tissue

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2

Management of a Chronic Skin Disease in Primary Care: An Analysis of Early-Career General Practitioners’ Consultations Involving Psoriasis

O12 Community Psoriasis: Phenotype and Comorbidity Assessment (COPPACA): an observational study of the prevalence, phenotype and health burden of psoriasis in the community

Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm

Evaluation of a Case Series of Patients With Generalized Pustular Psoriasis in the United States

Interdisciplinary approach to patients with psoriatic arthritis: a prospective, single-center cohort study

Epidemiology and Treatment of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis in Germany: A Real-World Evidence Study

Chinese Experts Consensus on Biologic Therapy for Psoriasis #

P045 An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis

How should electronic health records be designed? A cross-sectional study in patients with psoriasis

Analyzing the value of an educational program for psoriasis patients: a prospective controlled pilot study

Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry

Moderate Psoriasis in Clinical Practice: French Expert Consensus Using a Modified Delphi Method

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations

From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis

Generalized pustular psoriasis: A global Delphi consensus on clinical course, diagnosis, treatment goals and disease management

Expert Recommendations on Treating Psoriasis in Special Circumstances (Part II)

S3 Guideline for the treatment of psoriasis vulgaris, update – Short version part 1 – Systemic treatment